Ignite Creation Date:
2024-10-25 @ 7:56 PM
Last Modification Date:
2024-10-26 @ 3:38 PM
Study NCT ID:
NCT06561698
Status:
RECRUITING
Last Update Posted:
None
First Post:
2024-08-16
Brief Title:
High-dose Dual Therapy and Minocycline-cotaining Quadruple Therapy for Helicobacter Pylori Infection
Sponsor:
None
Organization:
None
Study Overview
Official Title:
High-dose Dual Therapy and Minocycline-cotaining Quadruple Therapy for Helicobacter Pylori Infection
Status:
RECRUITING
Status Verified Date:
2024-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study is a multicentra prospective study The enrolled patients are HP positive They are diagnosed as HP positive by rapid urease test andor 13C urea breath test According to the declaration of Helsinki 200 patients will be included in this study After obtaining the written informed consent of the patients HP culture and drug sensitivity test will be conducted on all the selected patients with the success rate adverse reactions compliance antibiotic resistance of HP and its impact on HP eradication
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None